Australia vs Finland: Reported rate of new cervical cancer cases
Australia
5.17 per 100,000 women
in 2017
Finland
5.28 per 100,000 women
in 2022
Australia rank
37th
Finland rank
36th
Reported rate of new cervical cancer cases over time
- Australia
- Finland
How they compare
Finland currently reports 5.28 per 100,000 women against 5.17 per 100,000 women in Australia, a difference of 0.11 per 100,000 women.
Across all 25 years both countries report, Australia has been ahead every year.
Australia ranks 37th and Finland ranks 36th of 46 countries.
Australia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Australia | Finland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 7.96 per 100,000 women | 4.14 per 100,000 women | 3.82 per 100,000 women | Australia |
| 2000s | 5.47 per 100,000 women | 4.03 per 100,000 women | 1.43 per 100,000 women | Australia |
| 2010s | 5.55 per 100,000 women | 4.51 per 100,000 women | 1.04 per 100,000 women | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Australia or Finland?
- Finland, at 5.28 per 100,000 women against 5.17 per 100,000 women in Australia as of 2022.
- What is the difference in reported rate of new cervical cancer cases between Australia and Finland?
- 0.11 per 100,000 women, with Finland ahead.
- How many years of comparable data are there for Australia and Finland?
- 25 years are reported by both, from 1993 to 2017.
- How do Australia and Finland rank globally for reported rate of new cervical cancer cases?
- Australia ranks 37th and Finland ranks 36th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.